Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	A-TU 750 mg	120
Overall Study	STARTED	A-TU 1000 mg	117
Overall Study	STARTED	B-TU 750 mg	22
Overall Study	STARTED	B-TU 1000 mg	112
Overall Study	STARTED	C-TU 750 mg	130
Overall Study	STARTED	C2-TU 750 mg	23
Overall Study	COMPLETED	A-TU 750 mg	75
Overall Study	COMPLETED	A-TU 1000 mg	74
Overall Study	COMPLETED	B-TU 750 mg	18
Overall Study	COMPLETED	B-TU 1000 mg	79
Overall Study	COMPLETED	C-TU 750 mg	93
Overall Study	COMPLETED	C2-TU 750 mg	21
Overall Study	NOT COMPLETED	A-TU 750 mg	45
Overall Study	NOT COMPLETED	A-TU 1000 mg	43
Overall Study	NOT COMPLETED	B-TU 750 mg	4
Overall Study	NOT COMPLETED	B-TU 1000 mg	33
Overall Study	NOT COMPLETED	C-TU 750 mg	37
Overall Study	NOT COMPLETED	C2-TU 750 mg	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00467870/flow